Augmedix (NASDAQ:AUGX) Coverage Initiated at B. Riley

B. Riley initiated coverage on shares of Augmedix (NASDAQ:AUGX – Free Report) in a report issued on Wednesday morning, Marketbeat reports. The firm issued a buy rating and a $5.50 target price on the stock. B. Riley also issued estimates for Augmedix’s Q1 2024 earnings at ($0.12) EPS, Q2 2024 earnings at ($0.13) EPS, Q3 […]

Related Keywords

United States ,Mian Shakil ,Barclays Plc ,Thompson Davis ,Worth Venture Partners ,Symmetry Peak Management ,Augmedix Inc ,Acadian Asset Management ,Maxim Group ,Free Report ,Asset Management ,Venture Partners ,Speak Management ,Get Free Report ,Augmedix Live ,Augmedix Go Assist ,Augmedix Prep ,Augmedix Daily ,Augmedix ,Nasdaq Augx ,Augx ,Medical ,Initiated Coverage ,B Riley ,